Alector, Inc.: insider trading
477 trades by 28 directors, officers and 10% owners since 2019, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$1.0 M
21 sales by 4 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$296 K
5 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (28)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Arnon RosenthalChief Executive Officer, Director | 2.51 M | — | $655 K | |
| Grace Wong-SaradPrincipal Accounting Officer | 161,570 | — | $99 K | |
| Neil Lindsay BerkleyCFO & Chief Business Officer | 395,216 | — | $221 K | |
| Elizabeth A. GarofaloDirector | 118,650 | — | — | |
| Errol B. DesouzaDirector | 98,650 | — | — | |
| Kristine YaffeDirector | 124,109 | — | — | |
| Louis J. Lavigne Jr.Director | 128,109 | — | — | |
| Mark AltmeyerDirector | 98,650 | — | — | |
| Paula HammondDirector | 103,609 | — | — | |
| Richard H. SchellerDirector | 134,899 | — | — | |
| Sara Kenkare-MitraPresident and Head of R&D | 501,652 | — | $47 K | |
| Marc GrassoChief Financial Officer | 296,072 | — | — | |
| Gary RomanoChief Medical Officer | 332,977 | — | — | |
| David M. WehnerDirector | 115,330 | — | — | |
| Polaris Venture Management Co. VI, L.L.C.10% owner | 0 | — | — | |
| Polaris Venture Partners VI (AIV), L.P.10% owner | 0 | — | — | |
| Terrance McGuireDirector, 10% owner | 54,996 | — | — | |
| Tillman U. GerngrossDirector | 2.64 M | — | — | |
| Robert KingChief Development Officer | 550,871 | — | — | |
| Shehnaaz SulimanPresident and COO | 102,598 | — | — | |
| Robert PaulChief Medical Officer | 234,319 | — | — | |
| Calvin YuVice President, Finance | 76,686 | — | — | |
| Orbimed Advisors LLC10% owner | — | — | — | |
| Sabah OneyChief Business Officer | 573,918 | — | — | |
| Orbimed Capital LLC10% owner | — | — | — | |
| OrbiMed Capital GP IV LLC10% owner | — | — | — | |
| Carl L. GordonDirector, 10% owner | — | — | — | |
| PVP VI (AIV) Feeder Corp. Holding Partnership, L.P.10% owner | — | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Grace Wong-SaradPrincipal Accounting Officer | Grant or award | +55,555 | — | — | 161,570 | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Grant or award | +44,567 | — | — | 395,216 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +217,500 | — | — | 2.51 M | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -3,625 | $2.510 | $9 K | 106,015 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -72,606 | $2.660 | $193 K | 2.29 M | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Sell | -29,251 | $2.660 | $78 K | 350,649 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -5,165 | $2.670 | $14 K | 109,640 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -656 | $2.750 | $2 K | 114,805 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Giftindirect | -1.05 M | — | — | 922,875 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Giftindirect | +350,000 | — | — | 1.00 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Giftindirect | +350,000 | — | — | 1.00 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Giftindirect | +350,000 | — | — | 1.00 M | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Grant or award | +20,000 | — | — | 115,461 | Form 4 |
| filed | Louis J. Lavigne Jr.Director | Grant or award | +28,700 | — | — | 128,109 | Form 4 |
| filed | Paula HammondDirector | Grant or award | +28,700 | — | — | 103,609 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +28,700 | — | — | 134,899 | Form 4 |
| filed | Kristine YaffeDirector | Grant or award | +28,700 | — | — | 124,109 | Form 4 |
| filed | Errol B. DesouzaDirector | Grant or award | +28,700 | — | — | 98,650 | Form 4 |
| filed | Elizabeth A. GarofaloDirector | Grant or award | +28,700 | — | — | 118,650 | Form 4 |
| filed | Mark AltmeyerDirector | Grant or award | +28,700 | — | — | 98,650 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -3,475 | $1.880 | $7 K | 95,461 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -5,709 | $1.970 | $11 K | 98,936 | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Sell | -19,360 | $1.970 | $38 K | 379,900 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -87,216 | $1.970 | $172 K | 2.37 M | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +10,833 | — | — | 106,199 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -1,820 | $2.650 | $5 K | 104,645 | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Grant or award | +54,600 | — | — | 399,260 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +116,246 | — | — | 2.45 M | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -1,000 | $2.650 | $3 K | 106,465 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -3,367 | $2.080 | $7 K | 107,465 | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Sell | -29,649 | $2.120 | $63 K | 344,660 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -8,071 | $2.120 | $17 K | 110,832 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -81,864 | $2.120 | $174 K | 2.34 M | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -4,079 | $2.500 | $10 K | 118,903 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -4,753 | $1.210 | $6 K | 122,982 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -104,347 | $1.120 | $117 K | 2.42 M | Form 4 |
| filed | Neil Lindsay BerkleyChief Bus Ofcr & Interim CFO | Sell | -37,261 | $1.120 | $42 K | 374,309 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -8,056 | $1.120 | $9 K | 127,735 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -41,687 | $1.120 | $47 K | 501,652 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +174,167 | — | — | 2.52 M | Form 4 |
| filed | Neil Lindsay BerkleyChief Bus Ofcr & Interim CFO | Grant or award | +65,000 | — | — | 411,570 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Grant or award | +32,343 | — | — | 135,791 | Form 4 |
| filed | Neil Lindsay BerkleyPrincipal Financial Officer | Sell | -15,842 | $2.500 | $40 K | 346,570 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -51,562 | $2.500 | $129 K | 2.35 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -23,638 | $2.500 | $59 K | 543,339 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -5,910 | $2.500 | $15 K | 103,448 | Form 4 |
| filed | Paula HammondDirector | Sell10b5-1 plan | -14,000 | $2.360 | $33 K | 74,909 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +137,125 | — | — | 2.55 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Grant or award | +54,725 | — | — | 566,977 | Form 4 |
| filed | Kristine YaffeDirector | Sell10b5-1 plan | -1,000 | $1.440 | $1 K | 95,409 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +28,700 | — | — | 95,366 | Form 4 |
| filed | Louis J. Lavigne Jr.Director | Grant or award | +28,700 | — | — | 99,409 | Form 4 |
| filed | Mark AltmeyerDirector | Grant or award | +28,700 | — | — | 69,950 | Form 4 |
| filed | Kristine YaffeDirector | Grant or award | +28,700 | — | — | 96,409 | Form 4 |
| filed | Errol B. DesouzaDirector | Grant or award | +28,700 | — | — | 69,950 | Form 4 |
| filed | Elizabeth A. GarofaloDirector | Grant or award | +28,700 | — | — | 89,950 | Form 4 |
| filed | Paula HammondDirector | Grant or award | +28,700 | — | — | 88,909 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -16,488 | $1.340 | $22 K | 296,072 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -52,087 | $1.340 | $70 K | 2.41 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -23,890 | $1.340 | $32 K | 512,252 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +15,833 | — | — | 66,666 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -16,306 | $1.470 | $24 K | 332,977 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -29,073 | $1.470 | $43 K | 536,142 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -18,091 | $1.470 | $27 K | 312,560 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -40,330 | $1.470 | $59 K | 2.47 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -26,500 | $2.520 | $67 K | 565,215 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -14,892 | $2.520 | $38 K | 349,283 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -52,172 | $2.520 | $131 K | 2.51 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -16,489 | $2.520 | $42 K | 330,651 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Grant or award | +300,000 | — | — | 591,715 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Grant or award | +216,400 | — | — | 347,140 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +610,500 | — | — | 2.56 M | Form 4 |
| filed | Gary RomanoChief Medical Officer | Grant or award | +184,380 | — | — | 364,175 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -7,297 | $4.880 | $36 K | 130,740 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -8,478 | $4.880 | $41 K | 179,795 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -13,926 | $4.880 | $68 K | 291,715 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -26,499 | $4.880 | $129 K | 1.95 M | Form 4 |
| filed | Richard H. SchellerDirector | Sell | -44,250 | $5.160 | $228 K | 35,000 | Form 4 |
| filed | Kristine YaffeDirector | Sell10b5-1 plan | -5,000 | $5.060 | $25 K | 67,709 | Form 4 |
| filed | Paula HammondDirector | Sell10b5-1 plan | -10,500 | $5.060 | $53 K | 60,209 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +15,833 | — | — | 50,833 | Form 4 |
| filed | Elizabeth A. GarofaloDirector | Grant or award | +35,000 | — | — | 61,250 | Form 4 |
| filed | Paula HammondDirector | Grant or award | +35,000 | — | — | 70,709 | Form 4 |
| filed | Kristine YaffeDirector | Grant or award | +35,000 | — | — | 72,709 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +35,000 | — | — | 79,250 | Form 4 |
| filed | David M. WehnerDirector | Grant or award | +35,000 | — | — | 115,330 | Form 4 |
| filed | Louis J. Lavigne Jr.Director | Grant or award | +35,000 | — | — | 70,709 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -25,135 | $4.800 | $121 K | 1.98 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -6,920 | $4.800 | $33 K | 138,037 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -13,206 | $4.800 | $63 K | 305,641 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -8,040 | $4.800 | $39 K | 188,273 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Otherindirect | -500,000 | — | — | 9.85 M | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | +98,533 | — | — | 98,533 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | -98,533 | — | — | 0 | Form 4 |
| filed | Polaris Venture Partners VI (AIV), L.P.10% owner | Otherindirect | -500,000 | — | — | 10.35 M | Form 4 |
| filed | Polaris Venture Partners VI (AIV), L.P.10% owner | Other | +98,533 | — | — | 98,533 | Form 4 |
| filed | Polaris Venture Partners VI (AIV), L.P.10% owner | Other | -98,533 | — | — | 0 | Form 4 |
| filed | Mark AltmeyerDirector | Grant or award | +41,250 | — | — | 41,250 | Form 4 |
| filed | Errol B. DesouzaDirector | Grant or award | +41,250 | — | — | 41,250 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -18,837 | $6.920 | $130 K | 2.00 M | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -6,001 | $6.920 | $42 K | 196,313 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -5,716 | $6.920 | $40 K | 144,957 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -10,169 | $6.920 | $70 K | 318,847 | Form 4 |
| filed | Elizabeth A. GarofaloDirector | Gift | -9,459 | — | — | 26,250 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -5,035 | $5.560 | $28 K | 202,314 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -12,519 | $5.560 | $70 K | 329,016 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -4,574 | $5.560 | $25 K | 150,673 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -23,831 | $5.560 | $133 K | 2.02 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Grant or award | +123,000 | — | — | 155,247 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Grant or award | +163,600 | — | — | 341,535 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +397,600 | — | — | 2.04 M | Form 4 |
| filed | Gary RomanoChief Medical Officer | Grant or award | +108,000 | — | — | 207,349 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Sellindirect | -500,000 | $6.000 | $3.0 M | 10.85 M | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Sellindirect | -500,000 | $6.000 | — | 10.85 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -5,647 | $5.190 | $29 K | 1.65 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -1,114 | $5.190 | $6 K | 32,247 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,771 | $5.190 | $14 K | 99,349 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -6,214 | $5.190 | $32 K | 177,935 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Otherindirect | -500,000 | — | — | 11.35 M | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | -500,000 | — | — | 11.35 M | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | +98,533 | — | — | 98,533 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Other | +6,429 | — | — | 54,996 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | -98,533 | — | — | 0 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | +98,533 | — | — | 98,553 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | -98,533 | — | — | 0 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | +13,133 | — | — | 39,399 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +8,541 | — | — | 44,250 | Form 4 |
| filed | Paula HammondDirector | Grant or award | +26,250 | — | — | 35,709 | Form 4 |
| filed | David M. WehnerDirector | Grant or award | +26,250 | — | — | 80,330 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Grant or award | +26,250 | — | — | 48,567 | Form 4 |
| filed | Elizabeth A. GarofaloDirector | Grant or award | +26,250 | — | — | 35,709 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +26,250 | — | — | 35,709 | Form 4 |
| filed | Kristine YaffeDirector | Grant or award | +26,250 | — | — | 35,709 | Form 4 |
| filed | Louis J. Lavigne Jr.Director | Grant or award | +26,250 | — | — | 35,709 | Form 4 |
| filed | Tillman U. GerngrossDirector | Grant or award | +26,250 | — | — | 2.64 M | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,617 | $6.900 | $18 K | 102,120 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -5,255 | $6.900 | $36 K | 1.65 M | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -4,092 | $6.900 | $28 K | 184,149 | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -1,050 | $6.900 | $7 K | 33,361 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -15,186 | $6.220 | $94 K | 1.66 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +42,990 | — | — | 1.67 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Sell | -1,291 | $8.320 | $11 K | 34,411 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Sell | -10,124 | $8.320 | $84 K | 188,241 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -5,849 | $8.320 | $49 K | 1.63 M | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -3,238 | $8.320 | $27 K | 104,737 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,145 | $8.710 | $19 K | 107,975 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Otherindirect | -500,000 | — | — | 11.85 M | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | -500,000 | — | — | 11.85 M | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Other | +6,429 | — | — | 22,317 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | +98,533 | — | — | 98,533 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | -98,533 | — | — | 0 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | +98,533 | — | — | 98,553 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | -98,533 | — | — | 0 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | +13,133 | — | — | 26,266 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Grant or award | +80,365 | — | — | 198,365 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +179,169 | — | — | 1.63 M | Form 4 |
| filed | Marc GrassoChief Financial Officer | Grant or award | +35,702 | — | — | 35,702 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Grant or award | +20,047 | — | — | 110,120 | Form 4 |
| filed | Robert KingChief Development Officer | Grant or award | +21,576 | — | — | 550,871 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -176 | $10.62 | $2 K | 529,295 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Sell | -2,177 | $10.62 | $23 K | 90,073 | Form 4 |
| filed | David M. WehnerDirector | Grant or award | +9,459 | — | — | 54,080 | Form 4 |
| filed | Terrance McGuireDirector | Grant or award | +9,459 | — | — | 15,888 | Form 4 |
| filed | Richard H. SchellerDirector | Grant or award | +9,459 | — | — | 9,459 | Form 4 |
| filed | Paula HammondDirector | Grant or award | +9,459 | — | — | 9,459 | Form 4 |
| filed | Kristine YaffeDirector | Grant or award | +9,459 | — | — | 9,459 | Form 4 |
| filed | Tillman U. GerngrossDirector | Grant or award | +9,459 | — | — | 2.62 M | Form 4 |
| filed | Louis J. Lavigne Jr.Director | Grant or award | +9,459 | — | — | 9,459 | Form 4 |
| filed | Elizabeth A. GarofaloDirector | Grant or award | +9,459 | — | — | 9,459 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -177 | $8.710 | $2 K | 529,471 | Form 4 |
| filed | Gary RomanoChief Medical Officer | Grant or award | +92,250 | — | — | 92,250 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -287 | $15.57 | $4 K | 528,404 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Grant or award | +59,000 | — | — | 59,000 | Form 4 |
| filed | Sara Kenkare-MitraPresident and Head of R&D | Grant or award | +59,000 | — | — | 118,000 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | -500,000 | — | — | 12.35 M | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Otherindirect | -500,000 | — | — | 12.35 M | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | +98,533 | — | — | 98,533 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Other | +6,429 | — | — | 6,429 | Form 4 |
| filed | Polaris Venture Management Co. VI, L.L.C.10% owner | Other | -98,533 | — | — | 0 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | +98,533 | — | — | 98,533 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | -98,533 | — | — | 0 | Form 4 |
| filed | Terrance McGuireDirector, 10% owner | Otherindirect | +13,133 | — | — | 13,133 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Option exercise | +75,000 | $17.23 | $1.3 M | 177,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -64,102 | $21.16 | $1.4 M | 113,496 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -10,898 | $21.73 | $237 K | 102,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Option exercise | +75,000 | $17.23 | $1.3 M | 177,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -66,126 | $21.69 | $1.4 M | 111,472 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -8,874 | $22.33 | $198 K | 102,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Option exercise | +75,000 | $17.23 | $1.3 M | 177,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -72,357 | $22.80 | $1.6 M | 105,241 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -2,643 | $23.40 | $62 K | 102,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Option exercise | +19,813 | $17.23 | $341 K | 122,411 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Option exercise | +55,187 | $10.24 | $565 K | 177,598 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -36,511 | $22.56 | $824 K | 141,087 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Sell10b5-1 plan | -38,489 | $23.01 | $886 K | 102,598 | Form 4 |
| filed | Robert KingChief Development Officer | Sell | -250 | $20.09 | $5 K | 528,691 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 1.97 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.03 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.08 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 652,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 652,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 652,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.14 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 667,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 667,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 667,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.19 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 682,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 682,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 682,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -55,000 | $25.00 | $1.4 M | 2.25 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 697,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 697,500 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -15,000 | $25.00 | $375 K | 697,500 | Form 4 |
| filed | Robert KingChief Development Officer | Grant or awardamended | +5,939 | — | — | 528,256 | Form 4/A |
| filed | Robert KingChief Development Officer | Grant or award | +7,967 | — | — | 530,284 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -9,625 | $25.10 | $242 K | 2.30 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -94,717 | $25.29 | $2.4 M | 2.32 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -5,283 | $26.10 | $138 K | 2.31 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -91,538 | $26.07 | $2.4 M | 2.42 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -8,462 | $26.56 | $225 K | 2.41 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -91,954 | $25.76 | $2.4 M | 2.52 M | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell10b5-1 plan · indirect | -8,046 | $26.33 | $212 K | 2.51 M | Form 4 |
| filed | Kristine YaffeDirector | Option exercise | +2,000 | $18.10 | $36 K | 2,000 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +9,691 | $8.160 | $79 K | 244,010 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +8,734 | $10.14 | $89 K | 252,744 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +4,525 | $17.15 | $78 K | 257,269 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -22,650 | $27.17 | $615 K | 234,619 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -300 | $27.79 | $8 K | 234,319 | Form 4 |
| filed | Richard H. SchellerDirector | Option exercise | +56,260 | $10.14 | $570 K | 56,260 | Form 4 |
| filed | Richard H. SchellerDirector | Sell | -52,868 | $27.64 | $1.5 M | 3,392 | Form 4 |
| filed | Richard H. SchellerDirector | Sell | -3,392 | $28.30 | $96 K | 0 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +7,292 | $8.160 | $60 K | 241,611 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +11,883 | $10.14 | $120 K | 253,494 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +10,574 | $17.15 | $181 K | 264,068 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -4,900 | $37.41 | $183 K | 259,168 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -7,700 | $38.14 | $294 K | 251,468 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -17,149 | $39.32 | $674 K | 234,319 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +30,000 | $17.15 | $515 K | 264,319 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,224 | $35.10 | $359 K | 254,095 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -3,600 | $35.95 | $129 K | 250,495 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -1,000 | $37.43 | $37 K | 249,495 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -3,581 | $38.55 | $138 K | 245,914 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -10,495 | $39.20 | $411 K | 235,419 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -1,100 | $40.01 | $44 K | 234,319 | Form 4 |
| filed | Calvin YuVice President, Finance | Option exercise | +1,042 | $8.160 | $9 K | 77,728 | Form 4 |
| filed | Calvin YuVice President, Finance | Option exercise | +625 | $10.14 | $6 K | 78,353 | Form 4 |
| filed | Calvin YuVice President, Finance | Option exercise | +1,667 | $17.15 | $29 K | 80,020 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -3,334 | $34.65 | $116 K | 76,686 | Form 4 |
| filed | Richard H. SchellerDirector | Sell10b5-1 plan | -9,981 | $31.14 | $311 K | 0 | Form 4 |
| filed | Robert KingChief Development Officer | Option exercise | +30,000 | $8.160 | $245 K | 552,317 | Form 4 |
| filed | Calvin YuVice President, Finance | Option exercise | +18,420 | $8.160 | $150 K | 145,106 | Form 4 |
| filed | Calvin YuVice President, Finance | Option exercise | +11,250 | $10.14 | $114 K | 156,356 | Form 4 |
| filed | Robert KingChief Development Officer | Option exercise | +30,000 | $10.14 | $304 K | 582,317 | Form 4 |
| filed | Robert KingChief Development Officer | Sell10b5-1 plan | -60,000 | $31.14 | $1.9 M | 522,317 | Form 4 |
| filed | Calvin YuVice President, Finance | Option exercise | +31,170 | $17.15 | $535 K | 187,526 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -90,840 | $31.14 | $2.8 M | 96,686 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -20,000 | $40.02 | $800 K | 76,686 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +17,326 | $17.15 | $297 K | 264,319 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -30,000 | $31.14 | $934 K | 234,319 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -26,726 | $22.23 | $594 K | 246,993 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +4,600 | $10.14 | $47 K | 278,319 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -4,600 | $22.18 | $102 K | 273,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +17,100 | $8.160 | $140 K | 290,819 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +12,900 | $10.14 | $131 K | 303,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -30,000 | $22.07 | $662 K | 273,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +7,292 | $8.160 | $60 K | 281,011 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +11,883 | $10.14 | $120 K | 292,894 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -16,175 | $19.00 | $307 K | 276,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -2,200 | $19.89 | $44 K | 274,519 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -800 | $20.83 | $17 K | 273,719 | Form 4 |
| filed | Calvin YuVice President, Finance | Sell10b5-1 plan | -1,844 | $17.77 | $33 K | 126,686 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +14,191 | $8.160 | $116 K | 287,910 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +784 | $10.14 | $8 K | 288,694 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -14,975 | $18.14 | $272 K | 273,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +2,900 | $8.160 | $24 K | 276,619 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +1,300 | $10.14 | $13 K | 277,919 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -4,200 | $18.04 | $76 K | 273,719 | Form 4 |
| filed | Shehnaaz SulimanPresident and COO | Grant or award | +100,000 | — | — | 100,000 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +150,000 | — | — | 1.46 M | Form 4 |
| filed | Robert PaulChief Medical Officer | Grant or award | +60,000 | — | — | 273,719 | Form 4 |
| filed | Robert KingChief Development Officer | Grant or award | +45,000 | — | — | 522,317 | Form 4 |
| filed | Calvin YuVice President, Finance | Grant or award | +16,000 | — | — | 126,686 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +17,092 | $8.160 | $139 K | 230,811 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +2,083 | $10.14 | $21 K | 232,894 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +3,125 | $17.15 | $54 K | 236,019 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -22,255 | $19.19 | $427 K | 213,764 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -45 | $19.83 | $892 | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +13,800 | $8.160 | $113 K | 227,519 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -13,800 | $22.21 | $306 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +30,000 | $8.160 | $245 K | 243,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -24,490 | $22.85 | $560 K | 219,229 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -5,510 | $23.55 | $130 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +17,092 | $8.160 | $139 K | 230,811 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +2,083 | $10.14 | $21 K | 232,894 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -19,175 | $18.12 | $347 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +17,091 | $8.160 | $139 K | 230,810 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +2,084 | $10.14 | $21 K | 232,894 | Form 4 |
| filed | Robert PaulChief Medical Officer | Sell10b5-1 plan | -19,175 | $20.81 | $399 K | 213,719 | Form 4 |
| filed | Robert PaulChief Medical Officer | Option exercise | +23,142 | $8.160 | $189 K | 236,861 | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice